Ara
Toplam kayıt 28, listelenen: 1-10
COVID-19: Hastalığı Artıran Risk Faktörleri ve Skorlama
(AVES Yayıncılık, 2021)
Şiddetli akut solunum sendromu virusu (SARS-CoV-2)’nun neden olduğu koronavirus hastalığı 2019 (COVID-19),
11 Mart 2020’de Dünya Sağlık Örgütü tarafından pandemi ilan edildikten sonra, kısa sürede büyük bir küresel ...
Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?
(AVES Yayıncılık, 2021)
Background: In this study, we aimed to investigate the efficacy and safety of sofosbuvir-based therapies in the treatment of chronic hepatitis C in real-world clinical practice.
Methods: Data from patients with chronic ...
Pandemi Sürecinde Kronik Hepatit C
(AVES Yayıncılık, 2021)
Şiddetli akut solunum sendromu virusu (SARS-CoV-2)’nun neden olduğu koronavirus hastalığı 2019 (COVID-19), dünyayı etkilemiş, önemli morbidite ve mortalite nedeni olmuştur. COVID-19, esas olarak pulmoner belirtilerle ortaya ...
Awareness of Hepatitis B Virus Reactivation Among Physicians Administering Immunosuppressive Treatment and Related Clinical Practices
(Aves, 2019)
Objective: This study aimed to evaluate the awareness and knowledge levels of all physicians administering immunosuppressive treatment concerning hepatitis B virus (HBV) reactivation, and draw attention to the importance ...
Hepatosteatozun Entekavir ve Tenofovir Tedavilerinde Virolojik Yanıta Etkisi
(Aves, 2019)
Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver. Therefore, the presence of hepatosteatosis might negatively affect the efficacy of antiviral therapy. We aimed to determine ...
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
(BMC, 04.05.2021)
Background and objectives
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose ...
Visual and Quantitative Assessment of COVID-19 Pneumonia on Chest CT: The Relationship with Disease Severity and Clinical Findings
(BENTHAM SCIENCE PUBL LTD, 2021)
Background: Lungs are the primary organ involved in COVID-19, and the severity of pneumonia in COVID-19 patients is an important cause of morbidity and mortality.
Aim: We aimed to evaluate the pneumonia severity through ...
AN OVERVIEW OF TRENDS IN INFECTIOUS DISEASE MORTALITY, TURKEY: 2009-2018
(NOBEL İLAÇ, 2021)
Objective: Infectious diseases continue to be one of the leading causes of death worldwide. This descriptive epidemiological study aimed to evaluate the trends in mortality from infectious diseases in Turkey from 2009 to ...
Neurological symptoms and findings in COVID-19: a prospective clinical study
(Taylor & Francis Group, 16.07.2021)
Objective: We sought to evaluate neurologic symptoms and findings in patients with COVID-
19 infection hospitalized in a ward and intensive care unit (ICU).
Methods: This study was designed as a prospective study. ...
INVESTIGATION OF THE IMMUNOMODULATOR EFFECT OF BETA GLUCAN IN THE EXPERIMENTAL INTRAABDOMINAL BACTERIEMIA MODEL WITH STAPHYLOCOCCUS AUREUS
(Afyonkarahisar Sağlık Bilimleri Üniversitesi, 2022)
OBJECTIVE: The purpose of this study is to investigate the immunomodulatory effect of beta glucan in an experimental model of intraabdominal bacteremia induced by S. aureus.
MATERIAL AND METHODS: Thirty Wistar albino rats ...